tips Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review January 26, 2015 BMC Pharmacology and Toxicology 2015, 16:1Â doi:10.1186/2050-6511-16-1 Published: 26 January 2015
